Komunikaty PR

Mobilisights Partners with Zubie to Enhance Fleet Management with Embedded Telematics Data

2025-04-30  |  01:55:03
Mobilisights and Zubie Logos

Mobilisights and Zubie Logos

Zubie will use the Mobilisights Fleet Plus Data Pack for access to embedded telematics data from millions of Stellantis N.V. vehicles in the United States

We are thrilled to partner with Zubie, who will leverage Stellantis' connected vehicle data to improve safety and efficiency for their fleet customers.”
— Eddie Nath, Mobilisights VP Sales for North America
DETROIT, MI, UNITED STATES, April 29, 2025 /EINPresswire.com/ -- Mobilisights, Stellantis’ Data as a Service business unit, is pleased to expand its customer base with a new agreement that provides Zubie with seamless access to data from Stellantis’ connected vehicles operating in the United States, allowing Zubie customers to optimize fleet and car rental operations with actionable insights. This agreement takes Mobilisights one step closer to its vision and mission of revolutionizing the experiences of customers and businesses with the transformative power of automotive data, contributing to a smarter and safer world.

Mobilisights is the exclusive source for embedded telematics data from Stellantis brands, harnessing insights from millions of the company’s vehicles. Without aftermarket devices, native vehicle data can be activated instantly, directly from the vehicle to the cloud. Refueling and EV charging become more efficient as fleet managers monitor fuel costs, charging status, vehicle range, and charge reimbursement. Vehicle health monitoring allows fleet managers to identify issues and schedule preventative maintenance, reducing unplanned downtime. Route optimization further decreases idle time, and increases fleet availability. Additionally, fleet managers can coach driver behavior, increase safety, and enhance the fleet's reputation.

For Zubie’s fleet customers, this collaboration delivers significant advantages in preventive maintenance, driver behavior monitoring, and overall vehicle health management. Access to Stellantis’ embedded data—via the Mobilisights Fleet Plus Data Pack— enables fleet operators to track signals in near real-time, including fuel efficiency, engine diagnostics, and odometer readings, without the complexity or cost of installing aftermarket devices. Combined with Zubie’s intuitive platform and diagnostic analytics, this integrated solution will reduce vehicle downtime, enhance driver safety, and lower operating costs across the fleets.

For Zubie’s car rental customers, access to Stellantis-connected vehicle data ensures near real-time visibility into vehicle location, fuel and charge levels, and diagnostic alerts—all critical for managing fast turnover rental inventory. Zubie Rental Connect customers can now benefit from Mobilisights’ OEM-grade insights to improve asset utilization, reduce administrative errors, streamline returns, and increase vehicle and driver protection with GPS location monitoring, and mechanical faults. These capabilities improve operational decision-making and enhance both customer satisfaction and profitability for rental operators.

“We are thrilled to partner with Zubie, who will leverage Stellantis' connected vehicle data to improve safety and efficiency for their fleet customers. This collaboration will enable Zubie, thanks to the quality of our data, to provide comprehensive asset management services by providing precise location, maintenance, fuel or charge levels — combined with improved driver oversight, thereby enhancing safety and reducing operational costs,” explains Aditya ‘Eddie’ Nath, VP Sales for Mobilisights North America.

“With Mobilisights, we have unique access to data insights from millions of connected Stellantis vehicles. While Zubie has long supported customers through OBD-based solutions, this evolution to OEM direct data access represents a significant leap forward. It reduces installation time, simplifies operations, and unlocks new efficiencies for our commercial fleet, rental, peer-to-peer, and dealership customers. We’re excited to continue leading the way in telematics innovation and delivering smarter, simpler solutions that scale with our customers’ needs,” shares Chad Caswell, CEO of Zubie. The company’s commitment to providing advanced telemetric solutions, customized for operators’ needs, creates incredible value in a difficult space.

Mobilisights integrates the latest digital solutions to keep pace with the evolving data privacy landscape. Data privacy and security is a top priority for Mobilisights, with end-to-end data stream protection. Data is only shared after explicit, informed consent is given.

About Zubie
Founded in 2012 and based in Bloomington, Minnesota, Zubie provides industry-leading connected vehicle data solutions for rental, commercial, and dealer fleets, enhancing efficiency and visibility with cutting-edge tracking software, hardware, and analytics. Trusted by thousands of businesses worldwide, Zubie seamlessly integrates into existing workflows and business systems, delivering unparalleled support and radical clarity to optimize asset management and simplify decision-making. For more information, visit www.zubie.com.

Zubie Media Contact
Nick McGuire, Director of Marketing at Zubie
nick.mcguire@zubie.com

About Mobilisights
Mobilisights is the Stellantis Data as a Service Company with unique access to embedded data telematics from fourteen automotive brands. Mobilisights envisions a ‘smarter’ world where innovative applications and services leverage connected vehicle datasets, and the insights they provide, to dramatically transform and continually improve everyday lives for consumers and businesses. For more information: www.mobilisights.com

Mobilisights Media Contact
Sarah Higgins / Dalyce Semko
mobilisights@open2europe.com
d.semko@open2america.com

About Stellantis
Stellantis N.V. (NYSE: STLA / Euronext Milan: STLAM / Euronext Paris: STLAP) is a leading global automaker, dedicated to giving its customers the freedom to choose the way they move, embracing the latest technologies and creating value for all its stakeholders. Its unique portfolio of iconic and innovative brands includes Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, FIAT, Jeep®, Lancia, Maserati, Opel, Peugeot, Ram, Vauxhall, Free2move and Leasys. For more information, visit www.stellantis.com.

Dalyce Semko
Open2America
+1 403-869-3259
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

NEXCOM EBC 370 Powers Autonomous Robotics for Industrial Applications

Highly Efficient, Edge AI Computing Delivered in a Compact New CPUThe EBC 370/EBC 370X is an AI-powered, PC-based controller designed to adapt to the most demanding conditions. Research labs use it as the main control unit for advanced robotics
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

The End Brain Cancer Initiative Partners with Curis to Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial

The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial REDMOND, WA, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE Contact: Dellann Elliott Mydland, 425-785-8489, Dellann@EndBrainCancer.org The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial The End Brain Cancer Initiative (EBCI) has partnered with Curis to promote awareness and pre-qualify patients for the company’s TakeAim Lymphoma Clinical Trial (CA-4948-101) clinical trial, an open-label, dose escalation and expansion trial of Emavusertib in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/​R PCNSL) (NCT03328078). “We are proud to partner with the End Brain Cancer Initiative to help raise awareness for primary CNS lymphoma (PCNSL), a rare and challenging form of cancer non-Hodgkin lymphoma. Together, we aim to highlight the unmet medical needs of this patient community, provide relevant resources to patients and their care providers, along with increasing awareness of clinical trials,” shared the Chief Medical Officer of Curis Inc, Ahmed Hamdy, MD. “Curis is committed to developing emavusertib for the treatment of PCNSL and broader non-Hodgkin lymphoma indications.” Patients who would like to learn more about this clinical trial and see if they qualify can visit https://endbraincancer.org/curis-therapeutics/ or contact the End Brain Cancer Initiative’s Clinical Research Coordinator and Patient Navigator, Shreya Prakash, at Shreya@EndBrainCancer.org or 425-436-8688. About Curis Curis, located in Lexington, Massachusetts, is a biotechnology company focused on the development of Emavusertib, an orally available, small molecule IRAK4 inhibitor. Emavusertib is currently being evaluated in the TakeAim Lymphoma Phase 1/2 study (CA-4948-101) in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the TakeAim Leukemia Phase 1/2 study (CA-4948-102) in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS), and as a frontline combination therapy with venetoclax and azacitidine in patents with AML (CA-4948-104). Emavusertib has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of PCNSL, AML and MDS and from the European Commission for the treatment of PCNSL. Curis, through its 2015 collaboration with Aurigene, has the exclusive license to Emavusertib (CA-4948). Curis licensed its rights to Erivedge® to Genentech, a member of the Roche Group, under which they are commercializing Erivedge® for the treatment of advanced basal cell carcinoma. For more information, visit Curis's website at https://www.curis.com/. About the End Brain Cancer Initiative To support/donate to the End Brain Cancer Initiative’s increased access and health delivery for patients, mission, services and programs, please visit EndBrainCancer.org The End Brain Cancer Initiative (EBCI) is a 501(c)3 non-profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative or how to sponsor this annual campaign at EndBrainCancer.org. Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, Dellann@EndBrainCancer.org
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 02:55:04

Uncle Sharkii Poke Bar Franchisees Honored with Multi-Unit Mastery Award

Uncle Sharkii franchisees Bruno and Jessica Picelli with the 2024 Multi-Unit Mastery Award.The award recognizes the longtime franchisees’ successful leadership and operational excellence across five Uncle Sharkii Poke Bar locations.From day

Kalendarium

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Profesjonalistów Public Relations

Ochrona środowiska

Z powodu braku przejrzystego prawa branża recyklingu odkłada inwestycje. Firmy apelują o szybkie wdrożenie przepisów

Branża recyklingu stoi przed wyzwaniami związanymi z wdrożeniem systemu kaucyjnego, systemu rozszerzonej odpowiedzialności producenta i rozporządzenia PPWR. Brakuje jednak odpowiednich przepisów dostosowujących polskie prawo i realia do unijnych regulacji. W efekcie utrzymującej się niepewności prawnej między 2018 a 2023 rokiem co trzeci zakład recyklingu zamknął działalność. Wiele firm odkłada inwestycje, czekając na uregulowanie rynku. Podobna niepewność dotyczy też producentów opakowań. 

Transport

Testowanie pojazdów zautomatyzowanych wkrótce będzie możliwe. To odpowiedź na postulaty przedsiębiorców

Kończą się prace nad przepisami, które mają usprawnić prace badawcze nad pojazdami zautomatyzowanymi. Ma to być odpowiedź na postulaty przedsiębiorców, którzy wskazywali na potrzebę pilnej zmiany przepisów w zakresie testowania pojazdów autonomicznych. Obecne regulacje nie sprzyjają postępowi technologicznemu i rozwoju autonomiczności pojazdów, o czym świadczy bardzo niewielka liczba wydanych uprawnień do ich prowadzenia.

Firma

Przedsiębiorcom coraz bardziej doskwiera niestabilność i skomplikowanie przepisów podatkowych. Problemem są też niejasne ich interpretacje

Polscy przedsiębiorcy często negatywnie oceniają jakość przepisów podatkowych – wynika z raportu „Przedsiębiorcy pod lupą fiskusa 2025” przygotowanego przez firmę doradztwa podatkowego MDDP we współpracy z Konfederacją Lewiatan. Ich niepokój budzą niejednolite interpretacje przepisów i niepewność prawa podatkowego, które cały czas jest modyfikowane. Wśród kluczowych zmian w obszarze podatków, które będą dotyczyć praktycznie wszystkich przedsiębiorców, są m.in. wprowadzenie Krajowego Systemu e-Faktur czy zmiany w podatku od nieruchomości.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.